SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

Never Miss a Story

Sign up for email alerts

 

More People & Company Headlines

Making sure the benefits outweigh the risks

Q&A with Stephens Mundy, CEO of University of Vermont Health Network (NY) Read Stephens Mundy's thoughts on the latest changes to the healthcare sector

Hospital Spotlight: Q&A with Peter Makowski The CEO of American Hospital Dubai in UAE talks about his unique role

Q&A with Victoria Steelman The president of AORN talks about the challenges and opportunities facing today's registered nurses

Surgical lasers and energy-based devices for surgery A primer on what's offered

Q&A with Babak Kateb The scientific director of the Society for Brain Mapping and Therapeutics (SBMT) discusses the upcoming annual meeting

Q&A with Dr. Mark Stibich The creator of the Xenex robot discusses the future of germ-zapping, reductions in HAIs, and the Ebola epidemic

The future of the health care supply chain GHX's Bruce Johnson shares his thoughts on the obstacles and opportunities

Practice Management - Clean is as clean does Why innovative engineering is needed to reduce transmission of germs

Q&A with Virtual Health CEO and CTO of Virtual Health discuss their patient engagement and population health management platform

Diversifying and protecting
the supply chain of radioisotopes

Lantheus Medical Imaging Takes Steps on Mo-99 Shortage

by Barbara Kram , Editor
N. BILLERICA, Mass. - Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, announced that it has signed an agreement with NTP Radioisotopes (Pty) Ltd., a subsidiary of the South African Nuclear Energy Corporation (NECSA), to manufacture and supply Lantheus with an ongoing volume of molybdenum-99 (Mo-99), a key isotope used in medical imaging procedures. This agreement underlines Lantheus' commitment to investing in a supply chain diversification strategy and providing new solutions to address the limited and fragile global Mo-99 supply chain, as evidenced by the current NRU reactor shutdown in Canada.1 Under the terms of this agreement, Lantheus will receive a specified supply of Mo-99 at regular intervals from NTP, enhancing the company's ability to meet and/or exceed customer demand. NTP has, in turn, partnered with Belgian radiochemical producer IRE to co-supply the Lantheus requirement and thereby maximize security of ongoing regular supplies of Mo-99 to Lantheus. IRE and NTP have a long and successful relationship as reliable and consistent suppliers of Mo-99 to key customers.

Global shortfalls of Mo-99 have recently impacted the availability of critical diagnostic imaging procedures, causing concern within the medical imaging industry. Mo-99 is the parent isotope of technetium-99m (Tc99m), the most widely utilized radioisotope in the world for molecular and nuclear diagnostic imaging procedures. There are only a few major suppliers of nuclear-reactor generated Mo-99 in the world. Mo-99 is primarily imported into the U.S. from aging and increasingly less reliable nuclear reactors. Recent problems within the global reactor structure have created instability in the supply of Mo-99, affecting the availability of the medical isotope to technetium generator manufacturers. Without adequate supply of Mo-99, crucial imaging tests must be canceled or postponed with potentially negative consequences for patients.

Story Continues Below Advertisement

We want to buy your Siemens Symphony or Avanto MRI -- today!

Top Dollar Paid, Fixed or Mobile. Call our Siemens Specialist for a Quote today -- 212-558-6600 Ext. 250 DOTmed Certified



"Partnering with NTP Radioisotopes as a reliable supplier of Mo-99 will provide us with expanded access within a limited supply chain. This partnership will bring our complementary skillsets and commitment to quality and reliability together to ensure patients have uninterrupted, timely access to needed medical imaging procedures that can diagnose life-threatening conditions such as heart disease and cancer," said Don Kiepert, president and CEO, Lantheus Medical Imaging, Inc. "Diversification of our supply chain and the introduction of new solutions in the marketplace to address the frequent worldwide medical isotope shortages is one of our foremost priorities as a company."

Continue reading Lantheus Medical Imaging Takes Steps on Mo-99 Shortage...
  Pages: 1 - 2 - 3 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Center
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED